Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients

Human Pathology

Volumn 29, Issue 1, 1998, Pages 60-64

  Fleming, M V ^a   Guinee D G , Jr ^a   Chu, W S ^a   Freedman, A N ^a   Caporaso, N E ^a   Bennett, W P ^a   Colby, T V ^a   Tazelaar, H ^a   Abbondanzo, S L ^a   Jett, J ^a   Pairolero, P ^a   Trastek, V ^a   Liotta, L A ^a   Harris, C C ^a   Travis, W D ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Apoptosis; Bcl 2; Immunohistochemistry; Lung carcinoma; Non small cell

Indexed keywords

AVIDIN; PEROXIDASE;

ADULT; APOPTOSIS; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; DATA ANALYSIS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION;

EID: 0031964567     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90391-4     Document Type: Article

References (23)

1. JFR Kerr CM Winterford BV Harmon Apoptosis: Its significance in cancer and cancer therapy Cancer 73 1994 2013 2026
2. DM Hockenbery The bcl-2 oncogene and apoptosis Semin Immunol 4 1992 413 420
3. T Miyashita JC Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
4. E Yang J Zha J Jockel Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death Cell 80 1995 285 291
5. JC Reed Bcl-2 and the regulation of programmed cell death J Cell Biol 124 1994 1 6
6. JJ Ryan E Prochownik CA Gottlieb c- myc and bcl -2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle ed 3 Proc Natl Acad Sci U S A 91 1994 5878 5882
7. 2+ fluxes ed 3 Proc Natl Acad Sci U S A 91 1994 6569 6573
8. MC Willingham K Bhalla Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis J Histochem Cytochem 42 1994 441 450
9. DM Hockenbery ZN Oltvai XM Yin Bcl-2 functions in an antioxidant pathway to prevent apoptosis Cell 75 1993 241 251
10. JMW Gee JFR Robertson IO Ellis Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy Int J Cancer 59 1994 619 628
11. N Ikegaki M Katsumata J Minna Expression of bcl-2 in small cell lung carcinoma cells Cancer Res 54 1994 6 8
12. QL Lu G Elia S Lucas Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma Int J Cancer 53 1993 29 35
13. FA Sinicrope SB Ruan KR Cleary Bcl -2 and p53 oncoprotein expression during colorectal tumorigenesis Cancer Res 55 1995 237 241
14. F Pezzella H Turley I Kuzu bcl-2 protein in non-small-cell lung carcinoma N Engl J Med 329 1993 690 694
15. JH Ritter CM Dresler MR Wick Immunoreactivity for bcl -2 protein in Stage I non-small cell lung carcinoma Am J Clin Pathol 102 1994 526 (abstr)
16. G Fontanini S Vignati D Bigini Bcl-2 protein: A prognostic factor inversely correlated with p53 in non-small-cell lung cancer Br J Cancer 71 1995 1003 1007
17. C Walker L Robertson M Myskow Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas Br J Cancer 12 1995 164 169
18. HR Katz bcl-2 protein in non-small-cell lung carcinoma N Engl J Med 330 1994 221 (letter)
19. EF Gaffney AJ O'Neill MJ Staunton bcl -2 and prognosis in non-small-cell lung carcinoma (letter) N Engl J Med 330 1994 1757 1758
20. DG Guinee Jr WD Travis GE Trivers Gender comparisons in human lung carcinoma: Analysis of p53 mutations, anti-p53 serum antibodies, and C-erbB2 expression Carcinogenesis 16 1995 993 1002
21. WD Travis LB Travis SS Devesa Lung Cancer Cancer 75 suppl 1 1995 191 202
22. S Rodenhuis van de Wetering WJ Mooi Mutational activation of the k- ras oncogene, a possible pathogenetic factor in adenocarcinoma of the lung N Engl J Med 317 1987 929 935
23. J Lorenz T Friedberg R Paulus Oncogene overexpression in non-small-cell lung cancer tissue: Prevalence and clinicopathologic significance Clin Invest 72 1994 156 163